Medscape October 5, 2023
HAMBURG, Germany — An international consensus report on precision diabetes medicine aims to further move the field from aspirational to actionable with a person-first focus.
“Diabetes recommendations often focus on what works well for the average person. However, because diabetes is an incredibly heterogeneous disease, few people are Mr or Mrs. ‘average’ and one-size-fits-all approaches fail many people in need. Precision medicine seeks to address this major problem,” said Precision Medicine in Diabetes Initiative (PDMI) co-chair Paul Franks, PhD, MPhil, head of the department of translational medicine at the Novo Nordisk Foundation in Denmark.
The report is the second from the joint American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) PDMI, a consortium organized in 2018 with...
Today's Sponsors
Today's Sponsor